Woodline Partners »

Bridgebio Oncology Therapeut shares owned by Woodline Partners

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 104k 11.58

More positions owned by Woodline Partners

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
At&t (T)
Chubb (CB)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Keysight Technologies (KEYS)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Merus N V (MRUS)
Autodesk (ADSK)

View all positions for Woodline Partners

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut